We are live on ! Find out more
MURA

Mural Oncology
MURA

Delisted

MURA was delisted on the 4th of December, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in Mural Oncology in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

30.72% less ownership

Funds ownership: 30.72% → 0% (-31%)

100% less funds holding

Funds holding: 61 → 0 (-61)

100% less capital invested

Capital invested by funds: $11M → $0 (-$11M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 61

Holders
–
Holders Change
-61
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
61
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$1.22M
2
NM
Newtyn Management
New York
-$1.08M
3
OAC
OMERS Administration Corp
Ontario, Canada
-$1.06M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$941K
5
RC
Rangeley Capital
Connecticut
-$631K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
– -$78.1K -37,712 Closed
Northern Trust
27
Northern Trust
Illinois
– -$68.9K -33,295 Closed
Raymond James Financial
28
Raymond James Financial
Florida
– -$37.7K -18,230 Closed
LP
29
LMR Partners
United Kingdom
– -$34K -16,417 Closed
Two Sigma Investments
30
Two Sigma Investments
New York
– -$30.4K -14,706 Closed
ACM
31
ADAR1 Capital Management
Texas
– -$24.5K -11,855 Closed
XT
32
XTX Topco
Cayman Islands
– -$21.8K -10,521 Closed
CL
33
CSS LLC
Illinois
– -$21.7K -10,500 Closed
Two Sigma Advisers
34
Two Sigma Advisers
New York
– -$21.1K -10,200 Closed
BNP Paribas Financial Markets
35
BNP Paribas Financial Markets
France
– -$4.92K -2,376 Closed
WSFS
36
Wilmington Savings Fund Society
Delaware
– -$4.3K -2,078 Closed
TRCT
37
Tower Research Capital (TRC)
New York
– -$3.87K -1,869 Closed
Osaic Holdings
38
Osaic Holdings
Arizona
– -$3.66K -1,761 Closed
MEG
39
Millstone Evans Group
Colorado
– -$3.58K -1,730 Closed
Wells Fargo
40
Wells Fargo
California
– -$2.42K -1,171 Closed
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
– -$2K -1,054 Closed
SAM
42
Storebrand Asset Management
Norway
– -$1.46K -705 Closed
UBS Group
43
UBS Group
Switzerland
– -$921 -445 Closed
AAM
44
Advisors Asset Management
Colorado
– -$857 -414 Closed
Fidelity Investments
45
Fidelity Investments
Massachusetts
– -$828 -400 Closed
Bank of America
46
Bank of America
North Carolina
– -$542 -262 Closed
EWA
47
EverSource Wealth Advisors
Alabama
– -$503 -243 Closed
JP Morgan Chase
48
JP Morgan Chase
New York
– -$480 -232 Closed
PNC Financial Services Group
49
PNC Financial Services Group
Pennsylvania
– -$128 -62 Closed
Barclays
50
Barclays
United Kingdom
– -$114 -55 Closed
1
2
3

MURA Hedge Fund Activity: Q4 2025 in Review

0 of the 8,224 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q4 2025, worth a combined $0 — down 100% from $11M a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of MURA and 0 opened new positions — a net loss of 61 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was OrbiMed, exiting entirely with an estimated $1.22M sold.

  • 0 institutional investors held Mural Oncology (MURA) as of Q4 2025, down from 61 in Q3 2025.
  • Funds reported $0 of Mural Oncology stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Mural Oncology positions in Q4 2025 and 61 closed out, a net change of -61 holders.
  • The largest Mural Oncology seller in Q4 2025 was OrbiMed, an estimated $1.22M sold.

Based on aggregated 13F filings for Q4 2025.